Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers

E-ISSN： 1538-7836|16|1|54-64

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.16, Iss.1, 2018-01, pp. : 54-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2722-2729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Air Ambulance Delivery and Administration of Four‐factor Prothrombin Complex Concentrate Is Feasible and Decreases Time to Anticoagulation Reversal

ACADEMIC EMERGENCY MEDICINE, Vol. 25, Iss. 1, 2018-01 ,pp. : 33-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re‐appraisal

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S187-S194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prothrombin Complex Concentrates for Urgent Anticoagulation Reversal in Patients with Intracranial Haemorrhage

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 5, 2009-12 ,pp. : 259-265

Karger

Access to resources Recommend Favorite

Should anti‐inhibitor coagulant complex and tranexamic acid be used concomitantly?

HAEMOPHILIA, Vol. 21, Iss. 6, 2015-11 ,pp. : 709-714

John Wiley & Sons Inc

Access to resources Recommend Favorite